Over 170 senior-level decision makers in Research and Development, Drug Discovery, in Licensing, Biomarkers and Clinical Development  from local and multinational pharma and biotech companies in China, South Korea, Japan, India and China

Over 40 presentations, case studies and panel discussions delivered by leading biotech companies, global pharma organisations & internationally renowned academic institutions

Do not miss out on the main themes of the event in 2015:

• Regulatory updates in the China and impact on multinational drug development activities
• Innovation strategies to advance R&D in Asia
• Overcoming challenges in developing a global regulatory strategy
• Types of R&D-CRO collaboration& business models
• Enabling technologies and novel methods in drug development, implementing Biomarkers, biometrics, data management and developing diagnostics

Co-located with the 4th Annual Clinical Development and Trials Asia Congress

Click here to download the agenda

Register here